Identiv announces stockholder approval of transaction with Vitaprotech (NASDAQ:INVE)

  • Identiv (NASDAQ:INVE) on Tuesday announced that its stockholders approved the asset sale transaction with Vitaprotech, a security solutions provider.
  • The company sought stockholder approval of the asset sale. Approximately 96% of shares voted were voted ‘FOR’ the asset sale proposal.
  • The transaction remains on track to close in the third quarter of 2024. Upon closing the transaction, Identiv will receive a cash payment of $145 million.
  • INVE +0.65% after hours to $4.137.
  • Source: Press Release